02.08.2011 • News

Luke Kissam Elected CEO of Albemarle

Luke C. Kissam will take over as Albemarles CEO on Sept.1.
Luke C. Kissam will take over as Albemarle's CEO on Sept.1.

Albemarle has promoted Luke C. Kissam to CEO, effective Sept.1. Kissam joined Albemarle in September 2003 as vice president, general counsel and corporate secretary and served as senior vice president, manufacturing and law, and corporate secretary from January 2008 until his promotion to president in March 2010.

Prior to joining Albemarle, Kissam served as vice president, general counsel and secretary of Merisant, having previously served as associate general counsel of Monsanto.

Current CEO Mark C. Rohr will continue as executive chairman of the Albemarle Board of directors.   

 

 

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Top-Feature

most read